ALTAMIRA THERAPEUTICS LTD (CYTO) Stock Analyst Ratings
NASDAQ:CYTO - Nasdaq - BMG0360L1349 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 83% to CYTO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 5.41. This target is 1702% above the current price.
CYTO was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CYTO.
In the previous month the buy percentage consensus was at a similar level.
CYTO was analyzed by 7 analysts. More opinions would make the average more meaningful.